Neuropsychiatric Disorders

Lactofem Probiotic May Boost SSRI Efficacy & Counteract Sexual Side Effects in Women with Depression (2024 Trial)

by

Probiotics may help improve sexual function and reduce depression severity in women treated with SSRIs. Highlights: Depression Prevalence: Approximately 5% of all adults will experience depressive disorder, often accompanied by reduced sexual desire and dysfunction. Study Design: The study was a double-blind randomized clinical trial involving 112 women with depressive disorder treated with SSRIs, comparing …

Read more

Cancer-Related Suicide Trends in the U.S. (40-Year Analysis) (2024)

by

A comprehensive study of nearly 5 million cancer patients over 40 years revealed fluctuating trends in cancer-related suicides in the U.S., with a recent significant decrease likely due to advancements in psychosocial care and cancer treatment. Highlights: Data: Analyzed data from 4,870,410 cancer patients in the US between 1975 and 2017. Trend: Suicide rates increased …

Read more

Depression Linked to Topographic & Dynamic Reorganization of Global Brain Activity (2024)

by

Major depressive disorder (MDD) involves a topographic reorganization of brain activity from sensory to associative regions, affecting symptom co-occurrence through changes in neural dynamics and excitation-inhibition balance. Highlights: Topographic Reorganization: MDD patients show a shift in brain activity from unimodal sensory regions to transmodal associative regions. Neural Dynamics: This shift includes changes in the brain’s …

Read more

Epigenetic Biomarkers Predict Delirium Diagnosis: DNA Methylation Patterns (2024 Study)

by

Epigenetic markers, specifically DNA methylation (DNAm) differences, show promise as diagnostic tools for detecting delirium, including post-operative delirium (POD), across multiple patient cohorts. Highlights: Significant DNAm Differences: Analysis of blood samples from four independent cohorts identified significant DNAm differences between patients with and without delirium, with 11 of the top 13 CpG sites showing consistent …

Read more

Antidepressant Mechanisms of Aerobic Exercise (2024 Review)

by

Aerobic exercise reduces depressive symptoms by decreasing inflammation, boosting dopamine transmission, and enhancing motivation and cognitive control. Highlights: Depression & Dopamine: Depression is linked to disrupted dopamine transmission, affecting reward processing and motivation, particularly in effort-based decision-making. Inflammation’s Role: Exercise reduces systemic inflammation, which otherwise impairs dopamine transmission and contributes to depressive symptoms like anhedonia …

Read more

Alcohol Use Disorder (AUD): Contributing Factors via Neuroclinical Addiction Analysis (2024)

by

A study broke down Alcohol Use Disorder (AUD) into specific brain-related categories and identified key factors that can help understand and classify AUD more accurately. Higlights: Cravings & Insensitivity: The study identified two main factors related to alcohol desire – one about craving alcohol and the other about not feeling its effects strongly. Emotions: Three …

Read more

Omega-3 Fatty Acids & Depression vs. Genetics: EPA-to-DHA Ratio (2024 Study)

by

Omega-3 fatty acids, particularly eicosapentaenoic acid (EPA), may reduce the risk of major depressive disorder (MDD), but causality remains uncertain due to potential pleiotropic mechanisms. Highlights: Genetic Evidence for Omega-3 & Depression: The study used two-sample Mendelian randomization to investigate the causality between genetically predicted omega-3 fatty acid levels and major depression, finding a protective …

Read more

Ketamine Alters Sleep Architecture in Depression: Delta Waves, Alpha Waves, Beta Waves (2024 Study)

by

A study examined the effects of ketamine on sleep arousal metrics in individuals with treatment-resistant depression (TRD) vs. healthy volunteers, finding that ketamine increases certain sleep-related brain activities but does not significantly mediate its antidepressant effects through these sleep changes. Highlights: Individuals with TRD had lower total sleep time and shorter REM latency compared to …

Read more

Case Report: Ozempic (Semaglutide) Worsening Depression in 54-Year-Old Female (2024)

by

GLP-1 receptor agonists like semaglutide, used for managing Type 2 diabetes, may be linked to adverse mood changes, necessitating further investigation into their psychiatric effects. Highlights: GLP-1 Receptor Agonists: These medications mimic GLP-1 hormone effects, enhancing insulin secretion and reducing appetite, commonly used for Type 2 diabetes management. Mood Effects: Data on the impact of …

Read more

Amphetamine Salts Cause Compulsive Biting & Chewing in 32-Year-Old Female with ADHD (2024 Case Report)

by

TLDR: A patient developed a compulsive chewing behavior when taking mixed amphetamine salts (MAS) for ADHD, highlighting the need to monitor for unusual side effects with stimulant use. Highlights: Patient Background: The patient is a 32-year-old woman with a history of GERD, gastroparesis, migraines, PTSD, generalized anxiety disorder, ADHD, and unspecified bipolar disorder. Medication & …

Read more

+ Load more